Global Proteomics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

List of Tables

The global demand for Proteomics Market is presumed to reach the market size of nearly USD 117.92 Billion by 2032 from USD 36.2 Billion in 2023 with a CAGR of 14.02% under the study period 2024-2032.

Proteomics studies proteins' structure, function, and interactions within a biological system. It involves the large-scale analysis of proteins, including their expression levels, post-translational modifications, and protein-protein interactions, to understand their roles in cellular processes, disease mechanisms, and biological pathways. It employs mass spectrometry, protein separation, and bioinformatics techniques to identify, quantify, and characterize proteins in complex biological samples. It is crucial in advancing our knowledge of molecular biology, biomarker discovery, drug development, and personalized medicine, offering insights into disease diagnosis, prognosis, and treatment.

MARKET DYNAMICS

The proteomics market is experiencing significant growth driven by advances in mass spectrometry, and bioinformatics are revolutionizing the field, enabling more precise and comprehensive analysis of proteins. This technological progress makes proteomics more accessible and efficient, thus fuelling its adoption in various research and clinical applications. Additionally, the spurring prevalence of chronic diseases, such as cancer & cardiovascular disorders, is driving the demand for proteomics-based diagnostics and therapeutics, as understanding protein functions and interactions is crucial for disease pathogenesis and treatment. Government and private sector investments in research are also bolstering the market, providing necessary funding for innovative projects and developments. The growing interest in personalized medicine further propels the market, as proteomic analysis plays a critical role in tailoring treatments to individual patients based on their unique protein profiles. Collaborations between academic institutions and biotechnology companies are fostering advancements, coupled with the increasing focus on biomarker discovery and drug development, collectively driving the market's growth, making it a pivotal area in modern biomedical research and healthcare. However, ethical concerns and regulatory hurdles may hinder the market's growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Proteomics. The growth and trends of Proteomics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Proteomics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Scope

Instruments
Reagents & Consumables
Services

By Application Scope

Drug Discovery
Clinical Diagnostics
Others

By Technology Scope

Microarray Instruments
X-Ray Crystallography
Spectroscopy
Chromatography
Protein Fractionation Systems
Electrophoresis
Surface Plasma Resonance (SPR) Systems

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Proteomics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Proteomics market include Illumina Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., GE Healthcare, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Promega Corp., Merck KGaA, Danaher. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11214795

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PROTEOMICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Scope
- 3.7.2 Market Attractiveness Analysis By Application Scope
- 3.7.3 Market Attractiveness Analysis By Technology Scope
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PROTEOMICS MARKET ANALYSIS BY PRODUCT SCOPE

5.1. Overview By Product Scope
5.2. Historical and Forecast Data Analysis By Product Scope
5.3. Instruments Historic and Forecast Sales By Regions
5.4. Reagents & Consumables Historic and Forecast Sales By Regions
5.5. Services Historic and Forecast Sales By Regions

6. GLOBAL PROTEOMICS MARKET ANALYSIS BY APPLICATION SCOPE

6.1. Overview By Application Scope
6.2. Historical and Forecast Data Analysis By Application Scope
6.3. Drug Discovery Historic and Forecast Sales By Regions
6.4. Clinical Diagnostics Historic and Forecast Sales By Regions
6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL PROTEOMICS MARKET ANALYSIS BY TECHNOLOGY SCOPE

7.1. Overview By Technology Scope
7.2. Historical and Forecast Data Analysis By Technology Scope
7.3. Microarray Instruments Historic and Forecast Sales By Regions
7.4. X-Ray Crystallography Historic and Forecast Sales By Regions
7.5. Spectroscopy Historic and Forecast Sales By Regions
7.6. Chromatography Historic and Forecast Sales By Regions
7.7. Protein Fractionation Systems Historic and Forecast Sales By Regions
7.8. Electrophoresis Historic and Forecast Sales By Regions
7.9. Surface Plasma Resonance (SPR) Systems Historic and Forecast Sales By Regions

8. GLOBAL PROTEOMICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PROTEOMICS COMPANIES

9.1. Proteomics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF PROTEOMICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Illumina Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Agilent Technologies Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Bio-Rad Laboratories Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. GE Healthcare
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Thermo Fisher Scientific Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. F. Hoffmann-La Roche Ltd.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Promega Corp.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Merck KGaA
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Danaher
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies